A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Ditching Invading DNA: Bacteria and archaea protect themselves from invasive foreign nucleic acids through an RNA-mediated adaptive immune system called CRISPR (clustered regularly interspaced short palindromic repeats)/CRISPR-associated (Cas). Jinek et al. (p. 816 , published online 28 June; see the Perspective by Brouns ) found that for the type II CRISPR/Cas system, the CRISPR RNA (crRNA) as well as the trans-activating crRNA—which is known to be involved in the pre-crRNA processing—were both required to direct the Cas9 endonuclease to cleave the invading target DNA. Furthermore, engineered RNA molecules were able to program the Cas9 endonuclease to cleave specific DNA sequences to generate double-stranded DNA breaks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To realize this promise, the development of CRISPR-Cas9 for genome editing offers a simpler technology that has been adopted widely due to the ease of programming its DNA binding and modifying capabilities.”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recombinant expression and purification of EvoCas9–1 paired with chemically synthesized Evo-generated single guide RNA (sgRNA) exhibited comparable in vitro cleavage activity to SpCas9 paired with the canonical SpCas9 sgRNA”
From Sequence modeling and design from molecular to genome scale with Evo (2024) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cas9 can create DNA cleavage at desired genomic positions that are guided by precise base pairing between sgRNA and DNA, adjacent to a protospacer-adjacent motif (PAM) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Jinek et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR/Cas9 is a class of ribonucleoprotein complexes formed by a Cas9 protein and a single guide RNA (sgRNA) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Jinek et al., 2012
Experimental — accuracy not yet measured
31 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
Self-citationSmall CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
Self-citationThe CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,328
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
A TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Christian, M., Cermak, T., Doyle, E. L., Schmidt, C., Zhang, F., Hummel, A., Bogdanove, A. J., & Voytas, D. F. (2010) · Genetics · doi:10.1534/genetics.110.120717 · Cited by 1,869
Cited by
Items 901–1,000 of 1,285
Site-directed nucleases: a paradigm shift in predictable, knowledge-based plant breeding
Podevin, N., Davies, H. V., Hartung, F., Nogué, F., & Casacuberta, J. M. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.03.004 · Cited by 214
CRISPR‐Cas9 Genome Editing in Drosophila
Gratz, S. J., Rubinstein, C. D., Harrison, M. M., Wildonger, J., & O'Connor‐Giles, K. M. (2015) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb3102s111 · Cited by 224
Mikuni, T., Nishiyama, J., Sun, Y., Kamasawa, N., & Yasuda, R. (2016) · Cell · doi:10.1016/j.cell.2016.04.044 · Cited by 214
CRISPR-Cas9 nuclear dynamics and target recognition in living cells
Ma, H., Tu, L.-C., Naseri, A., Huisman, M., Zhang, S., Grunwald, D., & Pederson, T. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201604115 · Cited by 218
“In the type II CRI SPR-Cas system, Cas9 and guide RNAs assemble into a ribonucleoprotein complex and act as a single-turnover JCB • Volume 214 • NumBer 5 • 2106532 enzyme to cleave target DNA highly efficiently in vitro (Jinek et al., 2012; Sternberg et al., 2015).”
BackgroundInfluentialGenome-wide CRISPR-dCas9 screens in E. coli identify essential genes and phage host factors
Rousset, F., Cui, L., Siouve, E., Becavin, C., Depardieu, F., & Bikard, D. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007749 · Cited by 230
What turns CREB on? And off? And why does it matter?
Steven, A., Friedrich, M., Jank, P., Heimer, N., Budczies, J., Denkert, C., & Seliger, B. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03525-8 · Cited by 213
Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy
Song, X., Liu, C., Wang, N., Huang, H., He, S., Gong, C., & Wei, Y. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.010 · Cited by 212
CRISPR-based genome editing through the lens of DNA repair
Nambiar, T. S., Baudrier, L., Billon, P., & Ciccia, A. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.12.026 · Cited by 208
Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system
Elmore, J. R., Sheppard, N. F., Ramia, N., Deighan, T., Li, H., Terns, R. M., & Terns, M. P. (2016) · Genes & Development · doi:10.1101/gad.272153.115 · Cited by 218
Multigene Knockout Utilizing Off-Target Mutations of the CRISPR/Cas9 System in Rice
Endo, M., Mikami, M., & Toki, S. (2015) · Plant and Cell Physiology · doi:10.1093/pcp/pcu154 · Cited by 213
“The specificity of CRISPR/Cas9-mediated DNA cleavage is determined by the 20 bp sequence in the single-guide RNA (sgRNA) and the NGG trinucleotide known as the protospacer-adjacent motif (PAM) that is recognized by Cas9 (Jinek et al. 2012).”
Douris, V., Steinbach, D., Panteleri, R., Livadaras, I., Pickett, J. A., Van Leeuwen, T., Nauen, R., & Vontas, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618258113 · Cited by 206
Kim, W., Ludlow, A. T., Min, J., Robin, J. D., Stadler, G., Mender, I., Lai, T.-P., Zhang, N., Wright, W. E., & Shay, J. W. (2016) · PLOS Biology · doi:10.1371/journal.pbio.2000016 · Cited by 209
Optimization of AsCas12a for combinatorial genetic screens in human cells
DeWeirdt, P. C., Sanson, K. R., Sangree, A. K., Hegde, M., Hanna, R. E., Feeley, M. N., Griffith, A. L., Teng, T., Borys, S. M., Strand, C., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-0600-6 · Cited by 218
Cas9 function and host genome sampling in Type II-A CRISPR–Cas adaptation
Wei, Y., Terns, R. M., & Terns, M. P. (2015) · Genes & Development · doi:10.1101/gad.257550.114 · Cited by 216
“As the effector nuclease of Type II CRISPR–Cas systems, Cas9 (guided by a crRNA/tracrRNA duplex) cuts opposing strands of complementary invading DNA using two nuclease domains (RuvC and HNH) (Garneau et al. 2010; Gasiunas et al. 2012; Jinek et al. 2012).”
InfluentialEngineered red blood cells as carriers for systemic delivery of a wide array of functional probes
Shi, J., Kundrat, L., Pishesha, N., Bilate, A., Theile, C., Maruyama, T., Dougan, S. K., Ploegh, H. L., & Lodish, H. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409861111 · Cited by 209
“To expedite RBC survival experiments, we created mice using CRISPR/Cas-9 genome-editing technology (14, 15), with LPETG inserted at the C terminus of the murine endogenous Kell gene (mKell-LPETG) (Tables S1–S3).”
Standardized Markerless Gene Integration for Pathway Engineering in Yarrowia lipolytica
Schwartz, C., Shabbir-Hussain, M., Frogue, K., Blenner, M., & Wheeldon, I. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00285 · Cited by 215
“and Charpentier, E. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.”
BackgroundDeaminase-mediated multiplex genome editing in Escherichia coli
Banno, S., Nishida, K., Arazoe, T., Mitsunobu, H., & Kondo, A. (2018) · Nature Microbiology · doi:10.1038/s41564-017-0102-6 · Cited by 216
Charpentier, E., & Doudna, J. A. (2013) · Nature · doi:10.1038/495050a · Cited by 210
Self-citationReal-space and real-time dynamics of CRISPR-Cas9 visualized by high-speed atomic force microscopy
Shibata, M., Nishimasu, H., Kodera, N., Hirano, S., Ando, T., Uchihashi, T., & Nureki, O. (2017) · Nature Communications · doi:10.1038/s41467-017-01466-8 · Cited by 210
Molecular networks in Network Medicine: Development and applications
Silverman, E. K., Schmidt, H. H. H. W., Anastasiadou, E., Altucci, L., Angelini, M., Badimon, L., Balligand, J., Benincasa, G., Capasso, G., Conte, F., et al. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1489 · Cited by 211
Molecular Mechanisms of CRISPR-Cas Immunity in Bacteria
Nussenzweig, P. M., & Marraffini, L. A. (2020) · Annual Review of Genetics · doi:10.1146/annurev-genet-022120-112523 · Cited by 214
CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems
Jiang, W., & Marraffini, L. A. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104441 · Cited by 208
pKAMA-ITACHI Vectors for Highly Efficient CRISPR/Cas9-Mediated Gene Knockout in Arabidopsis thaliana
Tsutsui, H., & Higashiyama, T. (2016) · Plant and Cell Physiology · doi:10.1093/pcp/pcw191 · Cited by 220
“Recently, a novel and revolutionary tool for genome engineering, called CRISPR (clustered regularly interspaced short palindromic repeats), has been developed (Jinek et al. 2012, Cong et al. 2013, Mali et al. 2013).”
MethodModern Trends in Plant Genome Editing: An Inclusive Review of the CRISPR/Cas9 Toolbox
Razzaq, A., Saleem, F., Kanwal, M., Mustafa, G., Yousaf, S., Imran Arshad, H. M., Hameed, M. K., Khan, M. S., & Joyia, F. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164045 · Cited by 205
“On the other hand, the HDR repair pathway is a highly accurate mechanism that needs a homologous template to mediate repair and can be used to attain precise changes like gene insertion and gene replacement [6,9,10].”
BackgroundInfluentialVarious Aspects of a Gene Editing System—CRISPR–Cas9
Janik, E., Niemcewicz, M., Ceremuga, M., Krzowski, L., Saluk-Bijak, J., & Bijak, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249604 · Cited by 197
Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learning
Xiang, X., Corsi, G. I., Anthon, C., Qu, K., Pan, X., Liang, X., Han, P., Dong, Z., Liu, L., Zhong, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23576-0 · Cited by 209
CRISPR/Cas9 and Genome Editing in Drosophila
Bassett, A. R., & Liu, J.-L. (2014) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2013.12.004 · Cited by 212
Next-Generation Breeding Strategies for Climate-Ready Crops
Razzaq, A., Kaur, P., Akhter, N., Wani, S. H., & Saleem, F. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.620420 · Cited by 200
CRISPR‐Cas Biochemistry and CRISPR‐Based Molecular Diagnostics
Weng, Z., You, Z., Yang, J., Mohammad, N., Lin, M., Wei, Q., Gao, X., & Zhang, Y. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202214987 · Cited by 203
Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq
Kim, D., Kim, S., Kim, S., Park, J., & Kim, J.-S. (2016) · Genome Research · doi:10.1101/gr.199588.115 · Cited by 208
“www.genome.org 10-nt “seed” region (Jinek et al. 2012; Cong et al. 2013; Pattanayak et al. 2013).”
Michno, J.-M., Wang, X., Liu, J., Curtin, S. J., Kono, T. J., & Stupar, R. M. (2015) · GM Crops & Food · doi:10.1080/21645698.2015.1106063 · Cited by 206
Epigenome Editing: State of the Art, Concepts, and Perspectives
Kungulovski, G., & Jeltsch, A. (2016) · Trends in Genetics · doi:10.1016/j.tig.2015.12.001 · Cited by 208
“Later, two more programmable DNA recognition domains were discovered, transcription activator-like (TAL) effector (TALE) arrays [14,15], in which one TALE repeat recognizes one base pair, and the CRISPR/Cas9 system [16], which is based onWatson/Crick base-pairing between a guide RNA and one strand of the target DNA.”
BackgroundDesign and analysis of CRISPR–Cas experiments
Hanna, R. E., & Doench, J. G. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0490-7 · Cited by 208
Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering
Hamilton, J. R., Tsuchida, C. A., Nguyen, D. N., Shy, B. R., McGarrigle, E. R., Sandoval Espinoza, C. R., Carr, D., Blaeschke, F., Marson, A., & Doudna, J. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109207 · Cited by 208
Self-citationOmole, A. E., & Fakoya, A. O. J. (2018) · PeerJ · doi:10.7717/peerj.4370 · Cited by 204
“The nickase (D10A mutant) and the eSpCas9 variants have both been 736 shown to substantially reduce off-targets effects while still maintaining their meticulous on-target 737 cleavage221,222, (4) Catalytically dead Cas9 (dCas9) variant is generated by mutating both domains (HNH and 738 RUvC-like)219-220. dCas9, when m…”
BackgroundInfluentialMeasuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9
Koo, T., Lee, J., & Kim, J.-S. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0103 · Cited by 207
“Essential portions of crRNA and tracrRNA can be linked to form a single-chain guide RNA (sgRNA) (Jinek et al., 2012).”
BackgroundSanmamed, M. F., Chester, C., Melero, I., & Kohrt, H. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw041 · Cited by 207
“Notably, with the advent of CRISPR/Cas9 technology [21], and with it the ability to perform complex gene editing with relative ease and speed, it is expected to improve most of these drawbacks and dramatically enhanced the value of GEMMs.”
BackgroundQi, W., Zhu, T., Tian, Z., Li, C., Zhang, W., & Song, R. (2016) · BMC Biotechnology · doi:10.1186/s12896-016-0289-2 · Cited by 207
“The CRISPR/Cas9 system is derived from Streptococcus pyogenes and possesses a protospacer adjacent motif (PAM) recognition sequence [2, 3].”
BackgroundShan, Y., Zhou, X., Huang, R., & Xing, D. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00073 · Cited by 209
Identifying chemogenetic interactions from CRISPR screens with drugZ
Colic, M., Wang, G., Zimmermann, M., Mascall, K., McLaughlin, M., Bertolet, L., Lenoir, W. F., Moffat, J., Angers, S., Durocher, D., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0665-3 · Cited by 219
“Now, with the advent of CRISPR technology and its adaptation to pooled library screens in mammalian cells, high-resolution chemogenetic screens can be carried out directly in human cells [4 – 7].”
BackgroundEngineered materials for in vivo delivery of genome-editing machinery
Tong, S., Moyo, B., Lee, C. M., Leong, K., & Bao, G. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0145-9 · Cited by 205
CRISPR–Act3.0 for highly efficient multiplexed gene activation in plants
Pan, C., Wu, X., Markel, K., Malzahn, A. A., Kundagrami, N., Sretenovic, S., Zhang, Y., Cheng, Y., Shih, P. M., & Qi, Y. (2021) · Nature Plants · doi:10.1038/s41477-021-00953-7 · Cited by 200
Ottaviano, G., Georgiadis, C., Gkazi, S. A., Syed, F., Zhan, H., Etuk, A., Preece, R., Chu, J., Kubat, A., Adams, S., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq3010 · Cited by 199
“Here, we report adoption and human application of CRISPRCas9 (9, 10) through the generation of universal donor anti-CD19 CAR (CAR19) T cells for children with R/R B-ALL.”
BackgroundPrecise integration of large DNA sequences in plant genomes using PrimeRoot editors
Sun, C., Lei, Y., Li, B., Gao, Q., Li, Y., Cao, W., Yang, C., Li, H., Wang, Z., Li, Y., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01769-w · Cited by 199
“CRISPR genome editing relies on a single guide RNA (sgRNA) to program Cas nuclease binding and DNA cleavage at specific genomic sites in living cells 10–12 .”
A Thermostable Cas9 with Increased Lifetime in Human Plasma
Harrington, L. B., Paez-Espino, D., Staahl, B. T., Chen, J. S., Ma, E., Kyrpides, N. C., & Doudna, J. A. (2017) · Nature Communications · doi:10.1038/s41467-017-01408-4 · Cited by 205
Self-citationArazoe, T., Miyoshi, K., Yamato, T., Ogawa, T., Ohsato, S., Arie, T., & Kuwata, S. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25662 · Cited by 207
Li, J., Manghwar, H., Sun, L., Wang, P., Wang, G., Sheng, H., Zhang, J., Liu, H., Qin, L., Rui, H., et al. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13020 · Cited by 204
“The Cas9 protein can bind and cleave genomic sites that are homologous to sgRNA, which may result in unwanted offtarget mutations (Jinek et al., 2012).”
BackgroundCRISPR-Cas9 ribonucleoprotein-mediated co-editing and counterselection in the rice blast fungus
Foster, A. J., Martin-Urdiroz, M., Yan, X., Wright, H. S., Soanes, D. M., & Talbot, N. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-32702-w · Cited by 210
High-efficiency genome editing in plants mediated by a Cas9 gene containing multiple introns
Grützner, R., Martin, P., Horn, C., Mortensen, S., Cram, E. J., Lee-Parsons, C. W. T., Stuttmann, J., & Marillonnet, S. (2021) · Plant Communications · doi:10.1016/j.xplc.2020.100135 · Cited by 214
“The discovery of the mode of action of the CRISPR/Cas9 system in 2012 has provided biologists with a useful tool for generating site-specific mutations in genes of interest in living organisms (Jinek et al., 2012; Cong et al., 2013; Mali et al., 2013).”
BackgroundCatarino, R. R., & Stark, A. (2018) · Genes & Development · doi:10.1101/gad.310367.117 · Cited by 210
“Targeted editing of specific genomic regions has been revolutionized recently by CRISPR–Cas9, which introduces double-strand breaks in target DNA sequences defined by sequence-complementary guide RNAs (gRNAs) (Jinek et al. 2012).”
BackgroundWard, J. D. (2015) · Genetics · doi:10.1534/genetics.114.172361 · Cited by 207
“An NGG motif (protospacer adjacent motif, PAM) must immediately follow the target sequence in the genome (Jinek et al. 2012; Ran et al. 2013).”
BackgroundInfluentialThe CRISPR–Cas system for plant genome editing: advances and opportunities
Kumar, V., & Jain, M. (2015) · Journal of Experimental Botany · doi:10.1093/jxb/eru429 · Cited by 203
Breaking-Cas—interactive design of guide RNAs for CRISPR-Cas experiments for ENSEMBL genomes
Oliveros, J. C., Franch, M., Tabas-Madrid, D., San-León, D., Montoliu, L., Cubas, P., & Pazos, F. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw407 · Cited by 210
“Specific nucleases whose substrate specificity is dictated by a bound RNA complementary to these foreign DNA fragments are used for cleaving forthcoming instances of the invading genetic material (5).”
BackgroundSynthetic Biology—The Synthesis of Biology
Ausländer, S., Ausländer, D., & Fussenegger, M. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201609229 · Cited by 206
A semisynthetic organism engineered for the stable expansion of the genetic alphabet
Zhang, Y., Lamb, B. M., Feldman, A. W., Zhou, A. X., Lavergne, T., Li, L., & Romesberg, F. E. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616443114 · Cited by 203
“In type II CRISPR-Cas systems, such as that from Streptococcus pyogenes (21, 22), the endonuclease Cas9 uses encoded RNAs [or their artificial mimics known as single-guide RNAs (sgRNAs) (23)] to introduce double-strand breaks in cDNA upstream of a 5′-NGG-3′ protospacer adjacent motif (PAM) (24), which then results in…”
BackgroundInfluentialCRISPR-Cas9 Based Genome Editing Reveals New Insights into MicroRNA Function and Regulation in Rice
Zhou, J., Deng, K., Cheng, Y., Zhong, Z., Tian, L., Tang, X., Tang, A., Zheng, X., Zhang, T., Qi, Y., et al. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.01598 · Cited by 204
The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit
Murugan, K., Babu, K., Sundaresan, R., Rajan, R., & Sashital, D. G. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.007 · Cited by 205
Genome Editing in Rice: Recent Advances, Challenges, and Future Implications
Mishra, R., Joshi, R. K., & Zhao, K. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01361 · Cited by 200
Application of different types of CRISPR/Cas-based systems in bacteria
Liu, Z., Dong, H., Cui, Y., Cong, L., & Zhang, D. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01431-z · Cited by 185
CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference
Hochstrasser, M. L., Taylor, D. W., Bhat, P., Guegler, C. K., Sternberg, S. H., Nogales, E., & Doudna, J. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405079111 · Cited by 202
Self-citationJung, J. H., & Altpeter, F. (2016) · Plant Molecular Biology · doi:10.1007/s11103-016-0499-y · Cited by 204
“These SSNs currently include zinc-finger nucleases (ZFN) (Kim et al. 1996), meganucleases (Smith et al. 2006), transcription activator-like effector nucleases (TALEN) (Christian et al. 2010; Morbitzer et al. 2010), and RNA guided nuclease (CRISPR/Cas) systems (Jinek et al. 2012).”
BackgroundMarshall, R., Maxwell, C. S., Collins, S. P., Jacobsen, T., Luo, M. L., Begemann, M. B., Gray, B. N., January, E., Singer, A., He, Y., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2017.12.007 · Cited by 207
Myers, S. A., Wright, J., Peckner, R., Kalish, B. T., Zhang, F., & Carr, S. A. (2018) · Nature Methods · doi:10.1038/s41592-018-0007-1 · Cited by 203
“We fused the catalytically-dead RNA-guided nuclease Cas9 (dCas9) 12, 13 to the engineered peroxidase APEX2 14 to biotinylate proteins at a defined genomic loci for subsequent enrichment and identification by liquid chromatography-mass spectrometry (LC-MS/MS) (Figure 1A and Supplemental Figure 1).…”
CRISPR/dC as9 platforms in plants: strategies and applications beyond genome editing
Moradpour, M., & Abdulah, S. N. A. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13232 · Cited by 193
“…the expression of target genes (Gearing, 2016). sgRNA A guide RNA (gRNA) is a single chimeric RNA formed by the fusion of tracrRNA and crRNA (Jinek et al., 2012). gRNAs containing two major regions of importance for CRISPR systems, the scaffold and spacer regions, are used to direct dCas9…”
BackgroundMethodHighly efficient homology‐directed repair using CRISPR/Cpf1‐geminiviral replicon in tomato
Vu, T. V., Sivankalyani, V., Kim, E., Doan, D. T. H., Tran, M. T., Kim, J., Sung, Y. W., Park, M., Kang, Y. J., & Kim, J. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13373 · Cited by 200
CRISPR/Cas9-based precise excision of SlHyPRP1 domain(s) to obtain salt stress-tolerant tomato
Tran, M. T., Doan, D. T. H., Kim, J., Song, Y. J., Sung, Y. W., Das, S., Kim, E., Son, G. H., Kim, S. H., Van Vu, T., et al. (2021) · Plant Cell Reports · doi:10.1007/s00299-020-02622-z · Cited by 198
Differential RNA-seq: the approach behind and the biological insight gained
Sharma, C. M., & Vogel, J. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.06.010 · Cited by 202
“This informed the subsequent development of an engineered tracrRNA-crRNA hybrid (sgRNA) to guide the Cas9 protein of the type II CRISPR-Cas system for eukaryotic genome editing [52] and many other novel applications [53].”
BackgroundCRISPR Immunity Drives Rapid Phage Genome Evolution in Streptococcus thermophilus
Paez-Espino, D., Sharon, I., Morovic, W., Stahl, B., Thomas, B. C., Barrangou, R., & Banfield, J. F. (2015) · mBio · doi:10.1128/mbio.00262-15 · Cited by 206
Kao, D., Lai, A. G., Stamataki, E., Rosic, S., Konstantinides, N., Jarvis, E., Di Donfrancesco, A., Pouchkina-Stancheva, N., Sémon, M., Grillo, M., et al. (2016) · eLife · doi:10.7554/elife.20062 · Cited by 197
DNA capture by a CRISPR-Cas9–guided adenine base editor
Lapinaite, A., Knott, G. J., Palumbo, C. M., Lin-Shiao, E., Richter, M. F., Zhao, K. T., Beal, P. A., Liu, D. R., & Doudna, J. A. (2020) · Science · doi:10.1126/science.abb1390 · Cited by 205
Self-citationWu, Q., Qian, W., Sun, X., & Jiang, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01362-9 · Cited by 200
Structural Plasticity of PAM Recognition by Engineered Variants of the RNA-Guided Endonuclease Cas9
Anders, C., Bargsten, K., & Jinek, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.020 · Cited by 201
“Upon RNADNA hybridization and formation of an R-loop structure, the Cas9 RuvC and HNH endonuclease domains catalyze site-specific cleavage of the two strands in the target DNA, generating a double-strand break (DSB) (Gasiunas et al., 2012; Jinek et al., 2012).”
BackgroundInfluentialDevelopment of a CRISPR-Cas9 Tool Kit for Comprehensive Engineering of Bacillus subtilis
Westbrook, A. W., Moo-Young, M., & Chou, C. P. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.01159-16 · Cited by 201
The Unexpected Diversity of Plant Organelle RNA Editosomes
Sun, T., Bentolila, S., & Hanson, M. R. (2016) · Trends in Plant Science · doi:10.1016/j.tplants.2016.07.005 · Cited by 202
Engineering biological systems using automated biofoundries
Chao, R., Mishra, S., Si, T., & Zhao, H. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.06.003 · Cited by 195
Development of an Agrobacterium‐delivered CRISPR/Cas9 system for wheat genome editing
Zhang, Z., Hua, L., Gupta, A., Tricoli, D., Edwards, K. J., Yang, B., & Li, W. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13088 · Cited by 201
“In contrast, the CRISPR/Cas9 system consists of a short guide RNA (sgRNA) and a conditional DNA nuclease Cas9 (Jinek et al., 2012).”
BackgroundInfluentialPramanik, D., Shelake, R. M., Park, J., Kim, M. J., Hwang, I., Park, Y., & Kim, J.-Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041878 · Cited by 194
“Generally, an off-target site with two mismatches in the seed region of protospacer (for example, off-target-2-1) had less chance to be recognized by on-target sgRNA-Cas9 complexes [19].”
BackgroundInfluentialForeign DNA capture during CRISPR–Cas adaptive immunity
Nuñez, J. K., Harrington, L. B., Kranzusch, P. J., Engelman, A. N., & Doudna, J. A. (2015) · Nature · doi:10.1038/nature15760 · Cited by 201
Self-citationEfficiency and Inheritance of Targeted Mutagenesis in Maize Using CRISPR-Cas9
Zhu, J., Song, N., Sun, S., Yang, W., Zhao, H., Song, W., & Lai, J. (2016) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.10.006 · Cited by 199
Huang, H., Chai, C., Li, N., Rowe, P., Minton, N. P., Yang, S., Jiang, W., & Gu, Y. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00044 · Cited by 201
Guk, K., Keem, J. O., Hwang, S. G., Kim, H., Kang, T., Lim, E.-K., & Jung, J. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.04.016 · Cited by 202
Automated multiplex genome-scale engineering in yeast
Si, T., Chao, R., Min, Y., Wu, Y., Ren, W., & Zhao, H. (2017) · Nature Communications · doi:10.1038/ncomms15187 · Cited by 202
Comprehensive Overview of Bottom-Up Proteomics Using Mass Spectrometry
Jiang, Y., Rex, D. A. B., Schuster, D., Neely, B. A., Rosano, G. L., Volkmar, N., Momenzadeh, A., Peters-Clarke, T. M., Egbert, S. B., Kreimer, S., et al. (2024) · ACS Measurement Science Au · doi:10.1021/acsmeasuresciau.3c00068 · Cited by 190
Yang, H., Wu, J.-J., Tang, T., Liu, K.-D., & Dai, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-07871-9 · Cited by 199
CRISPR/Cas-mediated genome editing in the rat via direct injection of one-cell embryos
Shao, Y., Guan, Y., Wang, L., Qiu, Z., Liu, M., Chen, Y., Wu, L., Li, Y., Ma, X., Liu, M., et al. (2014) · Nature Protocols · doi:10.1038/nprot.2014.171 · Cited by 201
Sequence features associated with the cleavage efficiency of CRISPR/Cas9 system
Liu, X., Homma, A., Sayadi, J., Yang, S., Ohashi, J., & Takumi, T. (2016) · Scientific Reports · doi:10.1038/srep19675 · Cited by 166
Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins
Hur, J. K., Kim, K., Been, K. W., Baek, G., Ye, S., Hur, J. W., Ryu, S.-M., Lee, Y. S., & Kim, J.-S. (2016) · Nature Biotechnology · doi:10.1038/nbt.3596 · Cited by 201
Wang, Z., Wang, S., Li, D., Zhang, Q., Li, L., Zhong, C., Liu, Y., & Huang, H. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.12884 · Cited by 195
“In this system, the mature dual CRISPR RNA (crRNA) consists of a crRNA and small trans -activating CRISPR RNA (tracrRNA), which forms a functional complex with the endonuclease Cas9 (Deltcheva et al. , 2011; Jinek et al. , 2012).”
Jansing, J., Sack, M., Augustine, S. M., Fischer, R., & Bortesi, L. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.12981 · Cited by 201
“HBT-pcoCas9 was a gift from Jen Sheen (Addgene plasmid #52254).”
BackgroundInfluentialRapidly evolving homing CRISPR barcodes
Kalhor, R., Mali, P., & Church, G. M. (2017) · Nature Methods · doi:10.1038/nmeth.4108 · Cited by 207
Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases
Konovalova, J., Gerasymchuk, D., Parkkinen, I., Chmielarz, P., & Domanskyi, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236055 · Cited by 197
Computational approaches for effective CRISPR guide RNA design and evaluation
Liu, G., Zhang, Y., & Zhang, T. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.11.006 · Cited by 201
“Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/CRISPR-associated (Cas) systems, such as Cas9 [46] and Cas12a (formerly Cpf1) [118], are the primary tools used for genome editing due to their various abilities to manipulate, detect, and image certain DNA and RNA sequences in the…”
BackgroundMethodPrime editing: advances and therapeutic applications
Zhao, Z., Shang, P., Mohanraju, P., & Geijsen, N. (2023) · Trends in Biotechnology · doi:10.1016/j.tibtech.2023.03.004 · Cited by 191
Structural basis for Cas9 off-target activity
Pacesa, M., Lin, C.-H., Cléry, A., Saha, A., Arantes, P. R., Bargsten, K., Irby, M. J., Allain, F. H.-T., Palermo, G., Cameron, P., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.026 · Cited by 198
Web-based design and analysis tools for CRISPR base editing
Hwang, G.-H., Park, J., Lim, K., Kim, S., Yu, J., Yu, E., Kim, S.-T., Eils, R., Kim, J.-S., & Bae, S. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2585-4 · Cited by 198
Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity
Jiang, W., Samai, P., & Marraffini, L. A. (2016) · Cell · doi:10.1016/j.cell.2015.12.053 · Cited by 202
“Whereas type I and II CRISPR immunity is very sensitive to mutations in the target sequence (especially in the ‘‘seed’’ region of the target) (Gasiunas et al., 2012; Jinek et al., 2012; Westra et al., 2012; Wiedenheft et al., 2011), type III immunity is unusually tolerant of such mutations (Goldberg et al.”
Yang, D., Scavuzzo, M. A., Chmielowiec, J., Sharp, R., Bajic, A., & Borowiak, M. (2016) · Scientific Reports · doi:10.1038/srep21264 · Cited by 200
CRISPR/Cas9 editing genome of extremophile Halomonas spp.
Qin, Q., Ling, C., Zhao, Y., Yang, T., Yin, J., Guo, Y., & Chen, G. Q. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.03.018 · Cited by 198
Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins
Hynes, A. P., Rousseau, G. M., Agudelo, D., Goulet, A., Amigues, B., Loehr, J., Romero, D. A., Fremaux, C., Horvath, P., Doyon, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05092-w · Cited by 198
Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
Xu, C., Lu, Z., Luo, Y., Liu, Y., Cao, Z., Shen, S., Li, H., Liu, J., Chen, K., Chen, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06522-5 · Cited by 193
Metadata
- Authors
- Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (HHMI), University of California, Berkeley, CA 94720, USA.
- University of Vienna (AT)
- Umeå Centre for Microbial Research (SE)
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Chylinski, Krzysztof
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2012-08-17
- Volume
- 337
- Issue
- 6096
- Pages
- 816-821
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6286148
- OpenAlex
- W2045435533
- Semantic Scholar
- 68d962effe5520777791bd6ec8ffa4b963ba4f38
- Cited by
- 17,116
- References
- 48
- Citations by year
- 2026: 1083 · 2025: 1512 · 2024: 1602 · 2023: 1572 · 2022: 1795 · 2021: 1793 · 2020: 1577 · 2019: 1344 · 2018: 1255 · 2017: 1141 · 2016: 1018 · 2015: 680 · 2014: 467 · 2013: 231 · 2012: 29
- FWCI
- 180.75
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, sequence-specific DNA cleavage, DNA double-strand breaks
- MeSH terms
- Bacteriophages, Base Sequence, Molecular Sequence Data, Nucleic Acid Conformation, Plasmids, RNA, Streptococcus pyogenes, Deoxyribonucleases, Type II Site-Specific, DNA Cleavage, DNA Breaks, Double-Stranded, Inverted Repeat Sequences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.